- West Virginia University School of Public Health
- Health Policy, Management, and Leadership
- West Virginia University School of Medicine
- Emergency Medicine
- PhD, West Virginia University
- MPA, West Virginia University
- MSW, West Virginia University
- BSW, West Virginia University
1. Davidov DM, Davis SM, Zhu M, Afifi TO, Kimber M, Goldstein AL, Pitre N, Gurka KK, Stocks C. Intimate partner violence-related hospitalizations in Appalachia and the non-Appalachian United States. PLoS One. 2017 Sep 8;12(9):e0184222. doi: 10.1371/journal.pone.0184222. eCollection 2017. PubMed PMID: 28886119; PubMed Central PMCID: PMC5590902.
2. Davis SM, Daily S, Kristjansson AL, Kelley GA, Zullig K, Baus A, Davidov D, Fisher M. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis. Harm Reduct J. 2017 May 17;14(1):25. doi: 10.1186/s12954-017-0156-z. PubMed PMID: 28514954; PubMed Central PMCID: PMC5436422.
3. Omaki E, Castillo R, Eden K, Davis S, McDonald E, Murtaza U, Gielen A; My Healthy Choices Decision Aid Study Team. Using m-health tools to reduce the misuse of opioid pain relievers. Inj Prev. 2017 Apr 6. pii: injuryprev-2017-042319.
4. Tadros A, Layman SM, Davis SM, Bozeman R, Davidov DM. Emergency department visits by pediatric patients for poisoning by prescription opioids. Am J Drug Alcohol Abuse. 2016 Jul 11:1-6. [Epub ahead of print]
About Steve Davis
Dr. Steve Davis has over 15 years of experience conducting emergency department research with specialization in stroke awareness and analyses of large-scale datasets to denote national trends in hospitalizations and emergency department utilization and care. He is a past Chair and current member of the West Virginia University Institutional Review Board. He regularly lectures on the ethical conduct of research and recently completed a book chapter on ethical issues in pharmaceutical research. Dr. Davis has a particular interest in the role of paraphernalia laws and policing behaviors on the efficacy of syringe access programs for the prevention of hepatitis C virus among rural Appalachian people who inject drugs.